Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01670708 · ClinicalTrials.gov registry record · NA

HOPE Demonstration Field Experiment Multisite Evaluation

A NA study of Substance Use and Criminal Recidivism, sponsored by RTI International.

Completed
Registry status
NA
Development phase
1,504
Enrollment target
4
Study locations

NCT01670708: Completed NA study of Substance Use and Criminal Recidivism, sponsored by RTI International.

NCT01670708 is a NA study of Substance Use and Criminal Recidivism that has completed, run by RTI International. The registered enrollment target is 1,504 participants, above the 1,243-participant average among 88 other Substance Use trials with a reported enrollment target (21% higher). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01670708, a NA study of Substance Use and Criminal Recidivism, has completed, sponsored by RTI International.

COMPLETED
Registry status
NA
Development phase
1,504 participants
Enrollment target
4
Study locations

Study Summary

The purpose of the Multisite Evaluation of the Honest Opportunity Probation with Enforcement Demonstration Field Experiment (the HOPE DFE Evaluation) is to conduct a randomized control trial (RCT) replication of the original Hawaii HOPE program and evaluation. The HOPE program provides strict oversight of probationers through a HOPE Court judge and intensive probation supervision, including random drug testing, coupled with swift and certain sanctions in response to positive results on random drug tests and other violations of conditions of supervision. The HOPE DFE Evaluation is being conducted among probation populations in four sites and will identify the effectiveness of swift and certain sanctions on targeted outcomes, both primary (appointment no-shows, positive urine tests, re-arrest rates) and secondary (revocation rates, jail days served, prison days sentenced).

Primary Outcome

Multiple measures to include percent positive for (1) marijuana, (2) cocaine, (3) heroin, (4) methamphetamine, and (5) any illegal drug on an oral swab drug test administered in conjunction with the 6 month follow-up interview (subjects in the community, i.e. not jailed or institutionalized, only).

Interventions

  • BEHAVIORAL HOPE
  • BEHAVIORAL Probation as Usual

Study Locations (4)

Arkansas

  • Court and Probation Office, Saline County - Benton

Massachusetts

  • Salem County Probation Office, Massachusetts Salem District Court, Essex County Superior Court - Salem

Oregon

  • Court and Probation Office - Oregon City

Texas

  • Court and Probation Office, Tarrant County - Fort Worth

Trial Details

FieldValue
Enrollment Target 1,504 participants
Start Date 2012-08
Est. Completion 2015-03-31
Phase NA
RTI International

45 total trials

What the finished NCT01670708 record still lists

NCT01670708 is an interventional study that assigns participants to a tested intervention. Its 1,504 participants enrollment target places it among the larger protocols in the corpus, above the 1,243-participant average among 88 other Substance Use trials with a reported enrollment target (21% higher).

The record links to 2 conditions, with Substance Use appearing as the primary indexed condition, and to 2 interventions - of which HOPE is the first listed.

NCT01670708 reports a single indexed study location in Arkansas, Massachusetts, Oregon.

Frequently Asked Questions

What is clinical trial NCT01670708 about?

NCT01670708 is a clinical study titled "HOPE Demonstration Field Experiment Multisite Evaluation". The purpose of the Multisite Evaluation of the Honest Opportunity Probation with Enforcement Demonstration Field Experiment (the HOPE DFE Evaluation) is to conduct a randomized control trial (RCT) replication of the original Hawaii HOPE program and evaluation. The HOPE program provides strict oversi...

What is the current status of trial NCT01670708?

This trial is currently completed. It is a NA study. The enrollment target is 1,504 participants. The study started on 2012-08. Estimated completion is 2015-03-31.

What conditions does trial NCT01670708 study?

This clinical trial studies the following conditions: Substance Use, Criminal Recidivism.

What interventions are being tested in trial NCT01670708?

The interventions under investigation include: HOPE (BEHAVIORAL), Probation as Usual (BEHAVIORAL).

Who is sponsoring clinical trial NCT01670708?

This trial is sponsored by RTI International, which has 45 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01670708 being conducted?

This trial has 4 study locations across Arkansas, Massachusetts, Oregon, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01670708's enrollment target sits among peer trials

1,504 6th of 88 higher than 83 of 88 other Substance Use trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00178724 · 1,500 participants

    Spinal Cord Injury Registry - North American Clinical Trials Network

  • NCT00951366 · 1,500 participants

    Preterm Lung Patient Registry

  • NCT01050504 · 1,500 participants

    Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

  • NCT02071134 · 1,500 participants

    Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01670708, the US trial registry maintained by the National Library of Medicine. NCT01670708 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.